ReproCELL develops diverse products focusing on human iPS/ES cell technology to address the needs of researchers and pharmaceutical companies. ReproCELL has a strong product portfolio in human iPS/ES cell culture reagents.
Professor Shinya Yamanaka, winner of the 2012 Nobel Prize for Physiology or Medicine, has been using our reagents since he established the world’s first human iPS cell line. ReproCELL has also launched innovative platforms, including the world’s first commercial product for human iPS cell-derived cardiomyocytes, neurons, and hepatocytes; demand for such platforms is rapidly growing in the drug screening market.
Through these strong and cutting-edge products, ReproCELL has the top market share in Japan. For continued growth, ReproCELL set up its Boston office in December 2012 to penetrate into the US market, which has a market size more than ten-fold that of Japan.